Literature DB >> 31439686

Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules.

Mathieu S Bolhuis1, Tjip S van der Werf2,3, Huib A M Kerstjens2,4, Wiel C M de Lange2,4, Jan-Willem C Alffenaar5,6, Onno W Akkerman2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31439686     DOI： 10.1183/13993003.00580-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Distribution of Linezolid in Tuberculosis Lesions in Patients with Spinal Multidrug-Resistant Tuberculosis.

Authors:  Yuan Li; Weijie Dong; Tinglong Lan; Jun Fan; Shibing Qin; Ai Guo
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis.

Authors:  Mahmoud Tareq Abdelwahab; Sean Wasserman; James C M Brust; Keertan Dheda; Lubbe Wiesner; Neel R Gandhi; Robin M Warren; Frederick A Sirgel; Graeme Meintjes; Gary Maartens; Paolo Denti
Journal:  Antimicrob Agents Chemother       Date:  2021-09-20       Impact factor: 5.191

3.  Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India.

Authors:  J A Tornheim; E Intini; A Gupta; Z F Udwadia
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-07-24

4.  Clinical standards for the dosing and management of TB drugs.

Authors:  J W C Alffenaar; S L Stocker; L Davies Forsman; A Garcia-Prats; S K Heysell; R E Aarnoutse; O W Akkerman; A Aleksa; R van Altena; W Arrazola de Oñata; P K Bhavani; N Van't Boveneind-Vrubleuskaya; A C C Carvalho; R Centis; J M Chakaya; D M Cirillo; J G Cho; L D Ambrosio; M P Dalcolmo; P Denti; K Dheda; G J Fox; A C Hesseling; H Y Kim; C U Köser; B J Marais; I Margineanu; A G Märtson; M Munoz Torrico; H M Nataprawira; C W M Ong; R Otto-Knapp; C A Peloquin; D R Silva; R Ruslami; P Santoso; R M Savic; R Singla; E M Svensson; A Skrahina; D van Soolingen; S Srivastava; M Tadolini; S Tiberi; T A Thomas; Z F Udwadia; D H Vu; W Zhang; S G Mpagama; T Schön; G B Migliori
Journal:  Int J Tuberc Lung Dis       Date:  2022-06-01       Impact factor: 3.427

Review 5.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

6.  Safety and Outcomes of Linezolid Use for Nocardiosis.

Authors:  Natalie Davidson; Matthew J Grigg; Sarah L Mcguinness; Robert J Baird; Nicholas M Anstey
Journal:  Open Forum Infect Dis       Date:  2020-03-16       Impact factor: 3.835

Review 7.  Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs.

Authors:  Marieke G G Sturkenboom; Anne-Grete Märtson; Elin M Svensson; Derek J Sloan; Kelly E Dooley; Simone H J van den Elsen; Paolo Denti; Charles A Peloquin; Rob E Aarnoutse; Jan-Willem C Alffenaar
Journal:  Clin Pharmacokinet       Date:  2021-03-06       Impact factor: 6.447

Review 8.  MDR Tuberculosis Treatment.

Authors:  Juan Espinosa-Pereiro; Adrian Sánchez-Montalvá; Maria Luisa Aznar; Maria Espiau
Journal:  Medicina (Kaunas)       Date:  2022-01-26       Impact factor: 2.430

9.  Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.

Authors:  Xubin Zheng; Lina Davies Forsman; Ziwei Bao; Yan Xie; Zhu Ning; Thomas Schön; Judith Bruchfeld; Biao Xu; Jan-Willem Alffenaar; Yi Hu
Journal:  Eur Respir J       Date:  2022-03-24       Impact factor: 16.671

Review 10.  Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria.

Authors:  Amaylia Oehadian; Prayudi Santoso; Dick Menzies; Rovina Ruslami
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.